Log In
BCIQ
Print this Print this
 

Serotonin (5-HT3) receptor

  Manage Alerts
Collapse Summary Pipeline Information
 Pipeline Summary for Products Targeting Serotonin (5-HT3) receptor

BCIQ
Print ChartPrint this
Marketed, 1 Marketed, 10 Approved, 1 Registration, 2 Phase III, 1 Phase III, 2 Phase II, 2 Phase I, 2 Phase I, 1 Preclinical, 3
Phase of DevelopmentPreclinicalPhase IPhase IIPhase IIIRegistrationApprovedMarketed
Gastrointestinal

3

1

-

2

2

1

10

Neurology

-

2

2

1

-

-

1




 Products Targeting Serotonin (5-HT3) receptor
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Summary
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

26

$107.7M

$13.3M

$51.8M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury Trial today